IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

CPhI: DSM Sinochem Pharmaceuticals to build Atorvastatin facility in India

8:06 AM MDT | October 15, 2012 | Deepti Ramesh in Madrid

DSM Sinochem Pharmaceuticals (DSP; Singapore), the former DSM Anti-Infectives business, says that it is planning to build production capacity for manufacturing the active pharmaceutical ingredient (API) for atorvastatin, the generic version of cholesterol-lowering drug Lipitor, at DSP’s existing production facility at Toansa, India. Pfizer’s Lipitor has been the top-selling drug worldwide. DSP says it is also considering manufacturing the finished dosage form of atorvastatin. “[Atorvastatin] will be an important business for the company and...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa